- Home
- TRSG vs LGVN Comparison
TRSG vs LGVN Comparison
Compare TRSG & LGVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRSG
- LGVN
- Stock Information
- Founded
- TRSG 1996
- LGVN 2014
- Country
- TRSG Singapore
- LGVN United States
- Employees
- TRSG N/A
- LGVN N/A
- Industry
- TRSG
- LGVN Medicinal Chemicals and Botanical Products
- Sector
- TRSG
- LGVN Health Care
- Exchange
- TRSG NYSE
- LGVN Nasdaq
- Market Cap
- TRSG 25.8M
- LGVN 23.4M
- IPO Year
- TRSG 2024
- LGVN 2021
- Fundamental
- Price
- TRSG $1.90
- LGVN $1.24
- Analyst Decision
- TRSG
- LGVN Strong Buy
- Analyst Count
- TRSG 0
- LGVN 3
- Target Price
- TRSG N/A
- LGVN $8.67
- AVG Volume (30 Days)
- TRSG 14.5K
- LGVN 123.3K
- Earning Date
- TRSG 05-14-2025
- LGVN 05-08-2025
- Dividend Yield
- TRSG N/A
- LGVN N/A
- EPS Growth
- TRSG N/A
- LGVN N/A
- EPS
- TRSG N/A
- LGVN N/A
- Revenue
- TRSG $12,810,249.00
- LGVN $2,225,000.00
- Revenue This Year
- TRSG N/A
- LGVN N/A
- Revenue Next Year
- TRSG N/A
- LGVN $17.49
- P/E Ratio
- TRSG N/A
- LGVN N/A
- Revenue Growth
- TRSG N/A
- LGVN 127.50
- 52 Week Low
- TRSG $1.00
- LGVN $0.77
- 52 Week High
- TRSG $5.16
- LGVN $6.40
- Technical
- Relative Strength Index (RSI)
- TRSG N/A
- LGVN 37.16
- Support Level
- TRSG N/A
- LGVN $1.25
- Resistance Level
- TRSG N/A
- LGVN $1.37
- Average True Range (ATR)
- TRSG 0.00
- LGVN 0.09
- MACD
- TRSG 0.00
- LGVN -0.01
- Stochastic Oscillator
- TRSG 0.00
- LGVN 1.75
About TRSG TUNGRAY TECHNOLOGIES INC
Tungray Technologies Inc is an engineer-to-order company that provides custom industrial manufacturing solutions to original equipment manufacturers in the semiconductor, printer, electronics, and home appliance industries. It predominantly generates revenue through the manufacture of custom industrial manufacturing solutions, direct drive and linear DC motors, and induction welding equipment. Geographically, the company generates a majority of its revenue from Singapore and the rest from China.
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.